anymedi, Inc. is engaged in manufacturing medical devices. It offers Surgical and Medical Instrument. The company was founded on December 14, 2016 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 390110 is 1,850 KRW — it has decreased by −0.44% in the past 24 hours. Watch ANYMEDI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ANYMEDI stocks are traded under the ticker 390110.
390110 stock has fallen by −2.76% compared to the previous week, the month change is a 9.76% rise, over the last year ANYMEDI has showed a −44.41% decrease.
390110 reached its all-time high on Jan 27, 2023 with the price of 12,650 KRW, and its all-time low was 1,015 KRW and was reached on Apr 22, 2024. View more price dynamics on 390110 chart. See other stocks reaching their highest and lowest prices.
390110 stock is 29.38% volatile and has beta coefficient of 0.07. Track ANYMEDI stock price on the chart and check out the list of the most volatile stocks — is ANYMEDI there?
No, 390110 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 390110 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANYMEDI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANYMEDI technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANYMEDI stock shows the neutral signal. See more of ANYMEDI technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.